Mechanisms of the urinary concentration defect and effect of desmopressin during endotoxemia in rats

Shock

Volumn 29, Issue 2, 2008, Pages 217-222

  Versteilen, Amanda M G ^a   Heemskerk, Astrid E J ^a   Groeneveld, A B Johan ^a,b   Van Wijhe, Michiel ^a   Van Lambalgen, Anton A ^a   Tangelder, Geert Jan ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Aquaporin 2; Collecting duct; Lipopolysaccharide; Osmolality; Vasopressin

Indexed keywords

AQUAPORIN 2; DESMOPRESSIN; ENDOTOXIN; ESCHERICHIA COLI ENDOTOXIN; POTASSIUM; SODIUM; UNCLASSIFIED DRUG; UREA; VASOPRESSIN V2 RECEPTOR; VASOPRESSIN V2 RECEPTOR AGONIST;

ACUTE KIDNEY FAILURE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENDOTOXEMIA; ESCHERICHIA COLI; FUNCTIONAL ASSESSMENT; HEMATOCRIT; IMMUNOHISTOCHEMISTRY; KIDNEY CONCENTRATING CAPACITY; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; OLIGURIA; OSMOLALITY; POTASSIUM URINE LEVEL; RAT; SEPSIS; SEPTIC SHOCK; SODIUM ABSORPTION; SODIUM URINE LEVEL;

ANIMALS; AQUAPORIN 2; DEAMINO ARGININE VASOPRESSIN; ENDOTOXEMIA; ENDOTOXINS; HEMODYNAMICS; IMMUNOHISTOCHEMISTRY; KIDNEY MEDULLA; KIDNEY TUBULES, COLLECTING; MALE; OSMOLAR CONCENTRATION; POTASSIUM; RATS; RATS, WISTAR; SODIUM; VASOPRESSINS;

EID: 38349098069     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/shk.0b013e3180ca9e53     Document Type: Article

References (35)

1. Liangos O, Rao M, Balakrishnan VS, Pereira BJ, Jaber BL: Relationship of urine output to dialysis initiation and mortality in acute renal failure. Nephron Clin Pract 99:c56-c60, 2005.
2. Hoste EA, Lameire NH, Vanholder RC, Benoit DD, Decruyenaere JM, Colardyn FA: Acute renal failure in patients with sepsis in a surgical ICU: predictive factors, incidence, comorbidity, and outcome. J Am Soc Nephrol 14:1022-1030, 2003.
3. Soubrier S, Leroy O, Devos P, Nseir S, Georges H, Escrivan T, Guery B: Epidemiology and prognostic factors of critically ill patients treated with hemodiafiltration. J Crit Care 21:66-72, 2006.
4. Diamond JR, Yoburn DC: Nonoliguric acute renal failure. Arch Intern Med 142:1882-1884, 1982.
5. Lucas CE, Rector FE, Werner M, Rosenberg IK: Altered renal homeostasis with acute sepsis. Clinical significance. Arch Surg 106:444-449, 1973.
6. Kompanowska-Jezierska E, Dobrowolski L, Sadowski J: Role of vasopressin V2 receptors in modulation of the renal cortico-papillary NaCl gradient. Pflugers Arch 428:410-414, 1994.
7. Mutlu GM, Factor P: Role of vasopressin in the management of septic shock. Intensive Care Med 30:1276-1291, 2004.
8. Granger JP, Alexander BT, Llinas M: Mechanisms of pressure natriuresis. Curr Hypertens Rep 4:152-159, 2002.
9. Holmes CL, Walley KR, Chittock DR, Lehman T, Russell JA: The effects of vasopressin on hemodynamics and renal function in severe septic shock: a case series. Intensive Care Med 27:1416-1421, 2001.
10. 2 receptor-mediated effects. Cardiovasc Res 51:372-390, 2001.
11. Jonassen TE, Graebe M, Promeneur D, Nielsen S, Christensen S, Olsen NV: Lipopolysaccharide-induced acute renal failure in conscious rats: effects of specific phosphodiesterase type 3 and 4 inhibition. J Pharmacol Exp Ther 303:364-374, 2002.
12. Heemskerk AE, Huisman E, Van Lambalgen AA, Van den Bos GC, Thijs LG, Tangelder GJ: Laparotomy and renal function during endotoxin shock in rats. Shock 6:410-417, 1996.
13. Kikeri D, Pennell JP, Hwang KH, Jacob AI, Richman AV, Bourgoignie JJ: Endotoxemic acute renal failure in awake rats. Am J Physiol 250(6 Pt 2):F1098-F1106, 1986.
14. Giusti-Paiva A, De Castro M, Antunes-Rodrigues J, Carnio EC: Inducible nitric oxide synthase pathway in the central nervous system and vasopressin release during experimental septic shock. Crit Care Med 30:1306-1310, 2002.
15. Heemskerk AE, Huisman E, Van Lambalgen AA, Van den Bos GC, Hennekes M, Thijs LG, Tangelder GJ: Renal function and oxygen consumption during bacteraemia and endotoxaemia in rats. Nephrol Dial Transplant 12:1586-1594, 1997.
16. Kasting NW, Mazurek MF, Martin JB: Endotoxin increases vasopressin release independently of known physiological stimuli. Am J Physiol 248:E420-E424, 1985.
17. 2 vasopressin receptors and aquaporin-2 content in the kidney medulla. Kidney Int 65:54-62, 2004.
18. Robben JH, Knoers NV, Deen PM: Cell biological aspects of the vasopressin type-2 receptor and aquaporin 2 water channel in nephrogenic diabetes insipidus. Am J Physiol Renal Physiol 291:F257-F270, 2006.
19. 2-receptor agonist/antagonist treatment. Am J Physiol Renal Physiol 278:F29-F42, 2000.
20. Hasler U, Mordasini D, Bens M, Bianchi M, Cluzeaud F, Rousselot M, Vandewalle A, Feraille E, Martin PY: Long-term regulation of aquaporin-2 expression in vasopressin-responsive renal collecting duct principal cells. J Biol Chem 277:10379-10386, 2002.
21. Sadowski J, Dobrowolski L: The renal medullary interstitium: focus on osmotic hypertonicity. Clin Exp Pharmacol Physiol 30:119-126, 2003.
22. Sun Q, Dimopoulos G, Nguyen DN, Tu Z, Nagy N, Hoang AD, Rogiers P, De Backer D, Vincent JL: Low-dose vasopressin in the treatment of septic shock in sheep. Am J Respir Crit Care Med 168:481-486, 2003.
23. Albert M, Losser MR, Hayon D, Faivre V, Payen D: Systemic and renal macro- and microcirculatory responses to arginine vasopressin in endotoxic rabbits. Crit Care Med 32:1891-1898, 2004.
24. Sakairi Y, Ando Y, Tabei K, Kusano E, Asano Y: Interleukin-1 inhibits sodium and water transport in rabbit cortical collecting duct. Am J Physiol 266:F674-F680, 1994.
25. Van der Post JA, Van Heerikhuize JJ, Boer K, Van Boxtel CE, Swaab DF: Radioimmunoassay of vasopressin during pregnancy. Use and removal of cystylaminopeptidase inhibitors. Clin Chim Acta 230:125-136, 1994.
26. Leemreis JR, Versteilen AM, Sipkema P, Groeneveld AB, Musters RJ: Digital image analysis of cytoskeletal F-actin disintegration in renal microvascular endothelium following ischemia/reperfusion. Cytometry A 69:973-978, 2006.
27. Hall JE, Montani JP, Woods LL, Mizelle HL: Renal escape from vasopressin: role of pressure diuresis. Am J Physiol 250:F907-F916, 1986.
28. Verbalis JG: Whole-body volume regulation and escape from antidiuresis. Am J Med 119(Suppl):21-29, 2006.
29. 2 by rat mesangial cells. Its contribution to arachidonic acid release and prostaglandin synthesis by cultured rat glomerular cells. J Clin Invest 92:2516-2523, 1993.
30. 2 analogue sulprostone antagonizes vasopressin-induced antidiuresis through activation of Rho. J Cell Sci 116:3285-3294, 2003.
31. 2 interaction with AVP: effects on AQP2 phosphorylation and distribution. Am J Physiol Renal Physiol 278:F388-F394, 2000.
32. 1 receptor-mediated inhibition of vasopressin action in inner medullary collecting duct. Am J Physiol 266:F791-F796, 1994.
33. Mattson DL: Importance of the renal medullary circulation in the control of sodium excretion and blood pressure. Am J Physiol Regul Integr Comp Physiol 284:R13-R27, 2003.
34. Salazar FJ, Llinas MT: Role of nitric oxide in the control of sodium excretion. News Physiol Sci 11:62-67, 1996.
35. Gong H, Wang W, Kwon TH, Jonassen T, Frokiaer J, Nielsen S: Reduced renal expression of AQP2, p-AQP2 and AQP3 in haemorrhagic shock-induced acute renal failure. Nephrol Dial Transplant 18:2551-2559, 2003.